Thermo Fisher finds India the perfect lab; lab equipment maker steps up investments as drug companies focus on innovation
Thermo Fisher Scientific announced it is increasing investments in India, driven by local drugmakers' focus on innovative medicines and biosimilars. The company expects double-digit returns over the next five years, citing India's rapid growth in the Asia-Pacific region. By 2030, India's biosimilars exports could rise from $800 million to $4.2 billion, highlighting significant market potential.